J. Alain Kummer

19.3k total citations · 3 hit papers
94 papers, 15.1k citations indexed

About

J. Alain Kummer is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, J. Alain Kummer has authored 94 papers receiving a total of 15.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 27 papers in Molecular Biology and 25 papers in Immunology. Recurrent topics in J. Alain Kummer's work include Immune Cell Function and Interaction (13 papers), Lymphoma Diagnosis and Treatment (11 papers) and Cancer-related Molecular Pathways (10 papers). J. Alain Kummer is often cited by papers focused on Immune Cell Function and Interaction (13 papers), Lymphoma Diagnosis and Treatment (11 papers) and Cancer-related Molecular Pathways (10 papers). J. Alain Kummer collaborates with scholars based in Netherlands, United States and Switzerland. J. Alain Kummer's co-authors include Chris J.L.M. Meijer, Peter J.F. Snijders, Jan M.M. Walboomers, M. Michele Manos, Marcel V. Jacobs, F. Xavier Bosch, Keerti V. Shah, Julian Peto, Ruud H. Brakenhoff and C. René Leemans and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and The Journal of Experimental Medicine.

In The Last Decade

J. Alain Kummer

92 papers receiving 14.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1999 7.0k citations Jan M.M. Walboomers, J. Alain Kummer et al. The Journal of Pathology profile →
A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.

2003 933 citations J. Alain Kummer, C. René Leemans et al. profile →
Notch1 functions as a tumor suppressor in mouse skin

2003 776 citations J. Alain Kummer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Alain Kummer Netherlands	52	6.6k	4.5k	3.6k	3.4k	2.7k	94	15.1k
Mark H. Stoler United States	63	10.9k 1.7×	3.2k 0.7×	4.3k 1.2×	5.6k 1.7×	1.8k 0.7×	272	17.0k
Denise A. Galloway United States	75	10.8k 1.6×	5.9k 1.3×	6.4k 1.8×	4.1k 1.2×	2.7k 1.0×	218	19.4k
Massimo Tommasino France	61	7.2k 1.1×	3.8k 0.8×	3.5k 1.0×	2.5k 0.8×	2.0k 0.7×	315	12.3k
Michael Pawlita Germany	70	8.8k 1.3×	6.1k 1.3×	5.4k 1.5×	5.0k 1.5×	4.0k 1.5×	408	20.6k
Magnus von Knebel Doeberitz Germany	71	5.7k 0.9×	4.9k 1.1×	6.7k 1.9×	3.8k 1.1×	2.3k 0.8×	319	16.3k
Mark E. Sherman United States	67	11.1k 1.7×	3.4k 0.8×	4.4k 1.2×	5.1k 1.5×	1.7k 0.6×	322	19.4k
Karl Münger United States	75	11.5k 1.7×	9.6k 2.1×	9.4k 2.6×	2.5k 0.8×	3.7k 1.4×	190	23.0k
Achim Schneider Germany	66	5.9k 0.9×	3.3k 0.7×	2.6k 0.7×	3.2k 1.0×	1.5k 0.6×	391	15.3k
Gary M. Clifford France	61	14.5k 2.2×	2.5k 0.5×	4.7k 1.3×	7.9k 2.3×	1.3k 0.5×	171	19.6k
Gemma G. Kenter Netherlands	64	4.5k 0.7×	2.5k 0.5×	5.2k 1.5×	3.6k 1.1×	5.0k 1.9×	234	14.4k

Countries citing papers authored by J. Alain Kummer

Since Specialization

Citations

This map shows the geographic impact of J. Alain Kummer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Alain Kummer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Alain Kummer more than expected).

Fields of papers citing papers by J. Alain Kummer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Alain Kummer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Alain Kummer. The network helps show where J. Alain Kummer may publish in the future.

Co-authorship network of co-authors of J. Alain Kummer

This figure shows the co-authorship network connecting the top 25 collaborators of J. Alain Kummer. A scholar is included among the top collaborators of J. Alain Kummer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Alain Kummer. J. Alain Kummer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roepman, Paul, et al.. (2018). Added Value of 50-Gene Panel Sequencing to Distinguish Multiple Primary Lung Cancers from Pulmonary Metastases. Journal of Molecular Diagnostics. 20(4). 436–445. 33 indexed citations

Wegelin, Olivier, Leonie Exterkate, Marloes van der Leest, et al.. (2018). The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies. European Urology. 75(4). 582–590. 192 indexed citations

Koning, Pieter J.A. de, J. Alain Kummer, Stefanie A.H. de Poot, et al.. (2011). Intracellular Serine Protease Inhibitor SERPINB4 Inhibits Granzyme M-Induced Cell Death. PLoS ONE. 6(8). e22645–e22645. 45 indexed citations

Dreijerink, Koen M.A., Radhika A. Varier, Olivier van Beekum, et al.. (2009). The Multiple Endocrine Neoplasia Type 1 (MEN1) Tumor Suppressor Regulates Peroxisome Proliferator-Activated Receptor γ-Dependent Adipocyte Differentiation. Molecular and Cellular Biology. 29(18). 5060–5069. 53 indexed citations

Koning, Pieter J.A. de, Kiki Tesselaar, Niels Bovenschen, et al.. (2009). The cytotoxic protease granzyme M is expressed by lymphocytes of both the innate and adaptive immune system. Molecular Immunology. 47(4). 903–911. 25 indexed citations

Versleijen‐Jonkers, Yvonne M.H., Sandra M.H. Claessen, Aurel Perren, et al.. (2007). DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients. Endocrine Related Cancer. 14(3). 769–779. 32 indexed citations

Kummer, J. Alain, Olivier Micheau, Pascal Schneider, et al.. (2007). Ectopic expression of the serine protease inhibitor PI9 modulates death receptor-mediated apoptosis. Cell Death and Differentiation. 14(8). 1486–1496. 25 indexed citations

Roepman, Paul, Dik van Leenen, Roel A. de Weger, et al.. (2006). Dissection of a metastatic gene expression signature into distinct components. Genome biology. 7(12). R117–R117. 33 indexed citations

Muris, Jettie J.F., C J Meijer, Saskia A.G.M. Cillessen, et al.. (2003). Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas. Leukemia. 18(3). 589–596. 77 indexed citations

10.

Kummer, J. Alain. (2003). Production, characterization, and use of serpin antibodies. Methods. 32(2). 141–149. 13 indexed citations

11.

Colnot, David R., Jan C. Roos, Remco de Bree, et al.. (2003). Safety, biodistribution, pharmacokinetics, and immunogenicity of 99m Tc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck. Cancer Immunology Immunotherapy. 52(9). 576–582. 52 indexed citations

12.

Bree, Remco de, Jasper J. Quak, J. Alain Kummer, Suat Şimşek, & C. René Leemans. (2003). Severe atherosclerosis of the radial artery in a free radial forearm flap precluding its use. Oral Oncology. 40(1). 99–102. 17 indexed citations

13.

Bladergroen, Bellinda A., Merel C. M. Strik, Niels Bovenschen, et al.. (2001). The Granzyme B Inhibitor, Protease Inhibitor 9, Is Mainly Expressed by Dendritic Cells and at Immune-Privileged Sites. The Journal of Immunology. 166(5). 3218–3225. 133 indexed citations

14.

Jenkins, David, Rashmi Seth, J. Alain Kummer, et al.. (2000). Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation. The Journal of Pathology. 190(2). 184–189. 26 indexed citations

15.

Blakolmer, Karin, Michael Vesely, J. Alain Kummer, et al.. (2000). Immunoreactivity of B-Cell Markers (CD79a, L26) in Rare Cases of Extranodal Cytotoxic Peripheral T- (NK/T-) Cell Lymphomas. Modern Pathology. 13(7). 766–772. 64 indexed citations

16.

Hoyer, Daniël, Dominique Fehlmann, Daniel Langenegger, et al.. (1998). High Affinity of SDZ HTF‐919 and Related Molecules for Calf and Human Caudate 5‐HT₄ Receptors. Annals of the New York Academy of Sciences. 861(1). 267–268. 11 indexed citations

17.

Mulder, W., Elisabeth Bloemena, M J Stukart, et al.. (1997). T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma.. Gut. 40(1). 113–119. 54 indexed citations

18.

Bruin, Peter C. de, et al.. (1997). Enteropathy‐associated T‐cell lymphomas have a cytotoxic T‐cell phenotype. Histopathology. 31(4). 313–317. 45 indexed citations

19.

Oberhuber, Georg, Harald Vogelsang, M. Stolte, et al.. (1996). Evidence that intestinal intraepithelial lymphocytes are activated cytotoxic T cells in celiac disease but not in giardiasis.. Europe PMC (PubMed Central). 148(5). 1351–7. 74 indexed citations

20.

Walboomers, Jan M.M., J W van Oostveen, M J Stukart, et al.. (1995). Lack of granzyme expression in T lymphocytes indicates poor cytotoxic T lymphocyte activation in human papillomavirus-associated cervical carcinomas. International Journal of Gynecological Cancer. 5(5). 366–373. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact